ARTICLE | Clinical News
Vapendavir: Ph IIb SPIRITUS data
February 23, 2017 2:13 AM UTC
Top-line data from the double-blind, international Phase IIb SPIRITUS trial in 168 evaluable patients ages 18-70 with moderate to severe asthma and laboratory-confirmed HRV infection showed that twice...
BCIQ Company Profiles
BCIQ Target Profiles